Do analysts recommend MODD or AEMD?

Aethlon Medical has a consensus target price of $1.50, suggesting a potential downside of 76.11%. Given Aethlon Medical's stronger consensus rating and higher probable upside, analysts clearly believe Aethlon Medical is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has better valuation & earnings, MODD or AEMD?

Modular Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Modular Medical N/A N/A -$28.24M -$8.69 N/A Aethlon Medical N/A N/A -$7.15M -$34.97 N/A

Is MODD or AEMD more profitable?

Aethlon Medical's return on equity of -123.08% beat Modular Medical's return on equity. Company Net Margins Return on Equity Return on Assets Modular Medical N/A -292.14% -222.79% Aethlon Medical N/A -123.08% -99.28%

Does the media favor ICU or AEMD?

In the previous week, SeaStar Medical had 7 more articles in the media than Aethlon Medical. MarketBeat recorded 8 mentions for SeaStar Medical and 1 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.75 beat SeaStar Medical's score of 0.22 indicating that Aethlon Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SeaStar Medical 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CTSO or AEMD?

In the previous week, Cytosorbents had 2 more articles in the media than Aethlon Medical. MarketBeat recorded 3 mentions for Cytosorbents and 1 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.75 beat Cytosorbents' score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cytosorbents 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend TMDIF or AEMD?

Aethlon Medical has a consensus target price of $1.50, suggesting a potential downside of 77.03%. Given Aethlon Medical's stronger consensus rating and higher possible upside, analysts clearly believe Aethlon Medical is more favorable than Titan Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is TMDIF or AEMD more profitable?

Titan Medical's return on equity of -82.31% beat Aethlon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Titan Medical N/A -82.31% -51.47% Aethlon Medical N/A -123.08% -99.28%

Does the media prefer AEMD or NMTC?

In the previous week, NeuroOne Medical Technologies had 7 more articles in the media than Aethlon Medical. MarketBeat recorded 8 mentions for NeuroOne Medical Technologies and 1 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.75 beat NeuroOne Medical Technologies' score of 0.72 indicating that Aethlon Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeuroOne Medical Technologies 2 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Aethlon Medical (AEMD) Competitors

$6.09 -0.44 (-6.74%)

Closing price 04:00 PM Eastern

Extended Trading

$6.20 +0.11 (+1.81%)

As of 06:51 PM Eastern

Compare

AEMD vs. MODD, ICU, CTSO, TMDIF, and NMTC

Should you buy Aethlon Medical stock or one of its competitors? Aethlon Medical's main competitors and comparable companies include Modular Medical (MODD), SeaStar Medical (ICU), Cytosorbents (CTSO), Titan Medical (TMDIF), and NeuroOne Medical Technologies (NMTC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Aethlon Medical compare to Modular Medical?

Modular Medical (NASDAQ:MODD) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

In the previous week, Aethlon Medical had 1 more articles in the media than Modular Medical. MarketBeat recorded 1 mentions for Aethlon Medical and 0 mentions for Modular Medical. Aethlon Medical's average media sentiment score of 0.75 beat Modular Medical's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Modular Medical	Neutral
Aethlon Medical	Positive

Modular Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 7.1% of Modular Medical shares are held by insiders. Comparatively, 0.6% of Aethlon Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Aethlon Medical has a consensus target price of $1.50, suggesting a potential downside of 76.11%. Given Aethlon Medical's stronger consensus rating and higher probable upside, analysts clearly believe Aethlon Medical is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Aethlon Medical's return on equity of -123.08% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-292.14%	-222.79%
Aethlon Medical	N/A	-123.08%	-99.28%

Modular Medical has a beta of 0.51, indicating that its share price is 49% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market.

Summary

Aethlon Medical beats Modular Medical on 9 of the 12 factors compared between the two stocks.

How does Aethlon Medical compare to SeaStar Medical?

SeaStar Medical (NASDAQ:ICU) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

Aethlon Medical has lower revenue, but higher earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	12.73	-$12.15M	-$3.91	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A

SeaStar Medical has a beta of -1.09, suggesting that its share price is 209% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market.

SeaStar Medical currently has a consensus price target of $8.00, indicating a potential upside of 125.35%. Aethlon Medical has a consensus price target of $1.50, indicating a potential downside of 77.03%. Given SeaStar Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe SeaStar Medical is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by insiders. Comparatively, 0.6% of Aethlon Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Aethlon Medical has a net margin of 0.00% compared to SeaStar Medical's net margin of -795.51%. Aethlon Medical's return on equity of -123.08% beat SeaStar Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-795.51%	-162.75%	-109.89%
Aethlon Medical	N/A	-123.08%	-99.28%

In the previous week, SeaStar Medical had 7 more articles in the media than Aethlon Medical. MarketBeat recorded 8 mentions for SeaStar Medical and 1 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.75 beat SeaStar Medical's score of 0.22 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SeaStar Medical	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aethlon Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Aethlon Medical beats SeaStar Medical on 8 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Cytosorbents?

Cytosorbents (NASDAQ:CTSO) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends.

Cytosorbents presently has a consensus target price of $107.50, indicating a potential upside of 2,614.65%. Aethlon Medical has a consensus target price of $1.50, indicating a potential downside of 77.03%. Given Cytosorbents' stronger consensus rating and higher possible upside, equities analysts clearly believe Cytosorbents is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytosorbents	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Cytosorbents has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market.

Aethlon Medical has a net margin of 0.00% compared to Cytosorbents' net margin of -48.94%. Aethlon Medical's return on equity of -123.08% beat Cytosorbents' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytosorbents	-48.94%	-431.65%	-41.94%
Aethlon Medical	N/A	-123.08%	-99.28%

In the previous week, Cytosorbents had 2 more articles in the media than Aethlon Medical. MarketBeat recorded 3 mentions for Cytosorbents and 1 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.75 beat Cytosorbents' score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cytosorbents	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aethlon Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aethlon Medical has lower revenue, but higher earnings than Cytosorbents. Cytosorbents is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytosorbents	$37.06M	0.34	-$8.20M	-$5.80	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A

32.9% of Cytosorbents shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 7.8% of Cytosorbents shares are owned by insiders. Comparatively, 0.6% of Aethlon Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Cytosorbents beats Aethlon Medical on 10 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Titan Medical?

Titan Medical (NASDAQ:TMDIF) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Titan Medical's return on equity of -82.31% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Aethlon Medical	N/A	-123.08%	-99.28%

0.0% of Titan Medical shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 0.0% of Titan Medical shares are held by insiders. Comparatively, 0.6% of Aethlon Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Aethlon Medical had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for Aethlon Medical and 0 mentions for Titan Medical. Aethlon Medical's average media sentiment score of 0.75 beat Titan Medical's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Titan Medical	Neutral
Aethlon Medical	Positive

Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market.

Aethlon Medical has a consensus target price of $1.50, suggesting a potential downside of 77.03%. Given Aethlon Medical's stronger consensus rating and higher possible upside, analysts clearly believe Aethlon Medical is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Titan Medical has higher revenue and earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.71	$6.95M	$0.05	2.20
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A

Summary

Titan Medical beats Aethlon Medical on 7 of the 13 factors compared between the two stocks.

How does Aethlon Medical compare to NeuroOne Medical Technologies?

Aethlon Medical (NASDAQ:AEMD) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. 0.6% of Aethlon Medical shares are held by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Aethlon Medical has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -71.50%. Aethlon Medical's return on equity of -123.08% beat NeuroOne Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-123.08%	-99.28%
NeuroOne Medical Technologies	-71.50%	-128.12%	-86.34%

In the previous week, NeuroOne Medical Technologies had 7 more articles in the media than Aethlon Medical. MarketBeat recorded 8 mentions for NeuroOne Medical Technologies and 1 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.75 beat NeuroOne Medical Technologies' score of 0.72 indicating that Aethlon Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeuroOne Medical Technologies	2 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aethlon Medical has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.77, indicating that its share price is 23% less volatile than the broader market.

Aethlon Medical presently has a consensus price target of $1.50, indicating a potential downside of 77.03%. NeuroOne Medical Technologies has a consensus price target of $7.33, indicating a potential upside of 557.70%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, analysts plainly believe NeuroOne Medical Technologies is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

NeuroOne Medical Technologies has higher revenue and earnings than Aethlon Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A
NeuroOne Medical Technologies	$9.47M	1.07	-$3.61M	-$0.95	N/A

Summary

NeuroOne Medical Technologies beats Aethlon Medical on 10 of the 15 factors compared between the two stocks.

Get Aethlon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AEMD vs. The Competition

Export

Metric	Aethlon Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.32M	$5.40B	$7.10B	$13.40B
Dividend Yield	N/A	1.81%	2.54%	17.38%
P/E Ratio	-0.17	25.29	273.97	26.32
Price / Sales	N/A	68.46	634.43	100.33
Price / Cash	N/A	32.73	27.22	34.74
Price / Book	0.39	5.97	11.09	6.35
Net Income	-$7.15M	$146.97M	$3.49B	$381.26M
7 Day Performance	-4.55%	-0.77%	-2.31%	-0.62%
1 Month Performance	234.62%	-4.84%	-7.06%	-4.85%
1 Year Performance	-84.25%	1.12%	5.65%	1.12%

Aethlon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AEMD Aethlon Medical	1.354 of 5 stars	$6.09 -6.7%	$1.50 -75.4%	-83.6%	$4.32M	N/A	N/A	9	Gap Down
MODD Modular Medical	0.2174 of 5 stars	$1.95 -3.0%	N/A	-88.7%	$16.34M	N/A	N/A	51
ICU SeaStar Medical	2.8042 of 5 stars	$3.56 +4.7%	$8.00 +124.7%	-45.3%	$14.98M	$1.23M	N/A	2	News Coverage High Trading Volume
CTSO Cytosorbents	3.2168 of 5 stars	$4.00 -0.5%	$107.50 +2,587.5%	-79.9%	$12.67M	$37.06M	N/A	129	Gap Up
TMDIF Titan Medical	N/A	$0.11 +6.8%	N/A	-77.1%	$12.59M	$17.63M	N/A	50

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AEMD) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aethlon Medical (AEMD) Competitors

AEMD vs. MODD, ICU, CTSO, TMDIF, and NMTC

How does Aethlon Medical compare to Modular Medical?

Summary

How does Aethlon Medical compare to SeaStar Medical?

Summary

How does Aethlon Medical compare to Cytosorbents?

Summary

How does Aethlon Medical compare to Titan Medical?

Summary

How does Aethlon Medical compare to NeuroOne Medical Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aethlon Medical (AEMD) Competitors

AEMD vs. MODD, ICU, CTSO, TMDIF, and NMTC

How does Aethlon Medical compare to Modular Medical?

Does the media prefer MODD or AEMD?

Which has better valuation & earnings, MODD or AEMD?

Do insiders and institutionals hold more shares of MODD or AEMD?

Do analysts recommend MODD or AEMD?

Is MODD or AEMD more profitable?

Which has more volatility & risk, MODD or AEMD?

Summary

How does Aethlon Medical compare to SeaStar Medical?

Which has better earnings & valuation, ICU or AEMD?

Which has more volatility and risk, ICU or AEMD?

Do analysts rate ICU or AEMD?

Do insiders & institutionals have more ownership in ICU or AEMD?

Is ICU or AEMD more profitable?

Does the media favor ICU or AEMD?

Summary

How does Aethlon Medical compare to Cytosorbents?

Do analysts recommend CTSO or AEMD?

Which has more volatility & risk, CTSO or AEMD?

Is CTSO or AEMD more profitable?

Does the media favor CTSO or AEMD?

Which has preferable earnings and valuation, CTSO or AEMD?

Do insiders & institutionals believe in CTSO or AEMD?

Summary

How does Aethlon Medical compare to Titan Medical?

Is TMDIF or AEMD more profitable?

Do insiders and institutionals believe in TMDIF or AEMD?

Does the media favor TMDIF or AEMD?

Which has more volatility & risk, TMDIF or AEMD?

Do analysts recommend TMDIF or AEMD?

Which has preferable earnings & valuation, TMDIF or AEMD?

Summary

How does Aethlon Medical compare to NeuroOne Medical Technologies?

Do insiders & institutionals have more ownership in AEMD or NMTC?

Is AEMD or NMTC more profitable?

Does the media prefer AEMD or NMTC?

Which has more risk and volatility, AEMD or NMTC?

Do analysts recommend AEMD or NMTC?

Which has higher earnings and valuation, AEMD or NMTC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools